
GC30913
DLK-IN-1
Also known as 5-[5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]-1-propan-2-ylpyrazol-3-yl]-3-(trifluoromethoxy)pyridin-2-amine
DLK-IN-1 is a selective, orally active inhibitor of dual leucine zipper kinase (DLK, MAP3K12), with a Ki of 3 nM
ChemicalCAS1620574-24-4MW423.43FormulaC20H24F3N5O2
- CAS number
- 1620574-24-4
- Molecular weight
- 423.43
- Formula
- C20H24F3N5O2
- Solubility
- DMSO : 62·5 mg/mL (147·60 mM)
- InChIKey
- UHEFRVBGJORHNV-UUVAVEHKSA-N
- Catalogue number
- GC30913
- Brand
- GLPBIO
Computed properties PubChem CID 90292823 · XLogP 2.2 · TPSA 78.4 Ų · H-bond donors 1
- XLogP
- 2.2
- TPSA
- 78.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 9
- Rotatable bonds
- 5
- Heavy atoms
- 30
SMILES CC(C)N1C(=CC(=N1)C2=CC(=C(N=C2)N)OC(F)(F)F)C3[C@H]4[C@@H]3CN(C4)C5COC5
Computed descriptors from PubChem (CID 90292823), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il